Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Soleno Therapeutics Stock Ticked Higher on Thursday


A 10% lift to an analyst's stock price on Soleno Therapeutics (NASDAQ: SLNO) provided some nice lift to the biotech's shares on Thursday. They closed the day's trading session nearly 2.4% higher, more than double the percentage-rate increase of the S&P 500 index.

Well before market open that day, Guggenheim healthcare analyst Debjit Chattopadhyay upped his price target on Soleno to $44 per share from his previous $40. In doing so, he maintained his buy recommendation on the shares. The new level implies nearly 12% upside to the stock at its latest closing price.

Chattopadhyay's latest research note on the company wasn't publicly available, so we can't ascertain the factors behind his price-target raise.

Continue reading


Source Fool.com

Like: 0
Share

Comments